Latest news
Piramal Alternatives exits Biodeal Pharma's Rs 110 Cr investment with 20%+ IRR - BioSpectrum IndiaBioSpectrum India · Mon, 27 Jul 2026 10:40:25 GMTPiramal Alternatives Exits Biodeal Pharma With Over 20% IRR - WhalesbookWhalesbook · Mon, 27 Jul 2026 08:54:44 GMTPiramal Alternatives exits Biodeal Pharma investment with over 20% IRR - Indian Pharma PostIndian Pharma Post · Sun, 26 Jul 2026 13:00:00 GMT